Office Based Addiction Treatment Training and Technical Assistance (OBAT TTA)

A Resource for Healthcare and Social Services Professionals

Buprenorphine Waiver Training for Providers

September 29, 2017
10:00 am–6:00 pm ET

This course educates physicians, nurse practitioners, and physician assistants on prescribing buprenorphine for the treatment of opioid use disorder.

Register now

Location

Beth Israel Deaconess Hospital - Plymouth
275 Sandwich Street
Funkhouser Conference Room
Plymouth, MA

Description

This eight-hour course prepares physicians, nurse practitioners, and physician's assistants to prescribe buprenorphine to treat opioid use disorder in their office. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete 8 hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours. Check-in for the course will begin at 9:30am and the training will run from 10:00 am to 6:00 pm. Breakfast and lunch will be provided.

Intended audience

Physicians (MD, DO), Nurse Practitioners, and Physician Assistants.

Objectives

Upon completion of this training, the participants will (be able to): Have the training required to apply for a waiver to prescribe buprenorphine to their patients with opioid dependence (addiction), Identify and assess patients who are appropriate for treatment with buprenorphine, Have the specific knowledge concerning the use of buprenorphine to manage opioid dependence in the outpatient setting, Discuss the psychiatric and medical co-morbidities associated with opioid addiction.

Sponsored by

PCSS Physician Clinical Support System, Boston Medical Center (BMC), Massachusetts Department of Public Health (DPH), American Academy of Addiction Psychiatry (AAAP), and the Massachusetts Bureau of Substance Abuse Services (BSAS).

Accreditation information

This program has no commercial support. Faculty and planners have no vested interests and there are no conflicts of interest. There will be no discussion of off label uses of drugs. Boston Medical Center is an approved provider of continuing nursing education by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. AMA Credit Designation Statement American Academy of Addiction Psychiatry (AAAP) designates this live educational activity for a maximum of 8 (eight) AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Funding for this initiative was made possible (in part) by Providers Clinical Support System for Medication Assisted Treatment (5U79TI024697) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Register now

OBAT TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for OBAT TTA is provided by:

Commonwealth of Massachusetts Department of Public Health
Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation

© 2021 Boston Medical Center. All rights reserved. Site by Signal.